Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerazette Predictive Impact on Nexplanon Bleeding
NCT01438736Phase 4Unknown
- Sponsor
- VL-Medi
- Start
- Sep 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of desogestrel in contraception, sponsored by VL-Medi. Status: unknown.
02
Drugs
desogestrel
03
Conditions
contraception
Beyond the preview
Go deeper on NCT01438736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01438736.